IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,133,788 | +1.7% | 135,783 | +12.4% | 0.00% | – |
| Q2 2023 | $1,114,743 | -31.7% | 120,774 | +1.7% | 0.00% | – |
| Q1 2023 | $1,632,311 | -20.1% | 118,800 | -1.0% | 0.00% | – |
| Q4 2022 | $2,042,017 | -21.0% | 120,048 | +5.6% | 0.00% | -100.0% |
| Q3 2022 | $2,584,000 | +29.6% | 113,649 | +2.8% | 0.00% | – |
| Q2 2022 | $1,994,000 | -11.9% | 110,606 | +30.6% | 0.00% | – |
| Q1 2022 | $2,264,000 | -0.5% | 84,672 | +9.2% | 0.00% | – |
| Q4 2021 | $2,275,000 | -57.0% | 77,544 | -3.7% | 0.00% | -100.0% |
| Q3 2021 | $5,295,000 | -37.8% | 80,514 | -21.3% | 0.00% | 0.0% |
| Q2 2021 | $8,508,000 | +7.6% | 102,254 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $7,909,000 | -22.0% | 103,131 | -10.2% | 0.00% | -50.0% |
| Q4 2020 | $10,142,000 | +14.5% | 114,869 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $8,854,000 | -10.5% | 119,947 | -11.5% | 0.00% | 0.0% |
| Q2 2020 | $9,895,000 | +96.1% | 135,552 | +50.8% | 0.00% | +100.0% |
| Q1 2020 | $5,046,000 | +82.0% | 89,860 | +23.6% | 0.00% | 0.0% |
| Q4 2019 | $2,773,000 | – | 72,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |